Primary completion· ClinicalTrials.gov
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works
Finerenone History and Updates
250 events · 2004 – present
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
3
FDA Approvals
0
Label Revisions
275
Trial Milestones
6
Pivotal Publications
Source: openFDA, ClinicalTrials.gov via AACT, PubMed · Hipa.ai, 2026-09-24Download chart as PNG
This page tracks every FDA action, clinical trial milestone, and major publication for Finerenone since 2004, drawn from openFDA, ClinicalTrials.gov, and PubMed.
All published updates (15)
2026
- Primary completionFinerenone Phase 3 hypertension and CKD trial withdrawn· Sep 17, 2026
- FDA approval (supplemental)Finerenone receives FDA supplemental efficacy approval for Kerendia· Sep 16, 2026
- Pivotal publicationFinerenone Study Results Published for Type 1 Diabetes and CKD· Jan 1, 2026
2025
- Primary completionFinerenone Completes Phase 3 Trial for Non-diabetic Chronic Kidney Disease· Dec 31, 2025
- Primary completionFinerenone Phase 3 Trial for Type 2 Diabetes Completes Primary Study· Nov 25, 2025
- Results postedFinerenone Reduces CV Death, HF Events in Heart Failure with LVEF ≥40%· Aug 26, 2025
- Primary completionFinerenone Phase 3 Trial for CKD and Type 1 Diabetes Completes· Aug 20, 2025
- FDA approval (supplemental)Kerendia (Finerenone) Receives FDA Supplemental Efficacy Approval· Jul 11, 2025
2024
- Pivotal publicationFinerenone Meta-Analysis on MRAs in Heart Failure Published in Lancet· Jan 1, 2024
- Pivotal publicationFinerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction…· Jan 1, 2024
2022
- FDA approval (supplemental)Finerenone: FDA approves supplemental efficacy application· Sep 1, 2022
2021
- FDA approvalFinerenone (Kerendia) received FDA approval as a new drug· Jul 9, 2021
- Pivotal publicationFinerenone: Cardiovascular Events in Kidney Disease and Type 2 Diabetes· Jan 1, 2021
2020
- Pivotal publicationEffect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes· Jan 1, 2020
2004
- Pivotal publicationFinerenone: Pivotal Publication on LV Mass Change in Hypertension· Jan 1, 2004
Upcoming & expected milestones
Primary completion· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ
Primary completion· ClinicalTrials.gov
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Trial started· ClinicalTrials.gov
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Primary completion· ClinicalTrials.gov
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Primary completion· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Primary completion· ClinicalTrials.gov
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Trial started· ClinicalTrials.gov
Precision T1D Platform - New Therapies for Cardio-Renal Complications
Primary completion· ClinicalTrials.gov
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Primary completion· ClinicalTrials.gov
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Primary completion· ClinicalTrials.gov
Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea
Primary completion· ClinicalTrials.gov
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Trial started· ClinicalTrials.gov
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Primary completion· ClinicalTrials.gov
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Primary completion· ClinicalTrials.gov
Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,
Primary completion· ClinicalTrials.gov
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,
Primary completion· ClinicalTrials.gov
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Primary completion· ClinicalTrials.gov
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Primary completion· ClinicalTrials.gov
Finerenone and Cardiac Remodeling in HFpEF
Primary completion· ClinicalTrials.gov
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and T
Primary completion· ClinicalTrials.gov
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Primary completion· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Primary completion· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATI
Primary completion· ClinicalTrials.gov
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Primary completion· ClinicalTrials.gov
Finerenone for Premature Ovarian Insufficiency (POI)
Primary completion· ClinicalTrials.gov
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Primary completion· ClinicalTrials.gov
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Primary completion· ClinicalTrials.gov
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme
Primary completion· ClinicalTrials.gov
Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With A
Primary completion· ClinicalTrials.gov
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece
Primary completion· ClinicalTrials.gov
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece
Primary completion· ClinicalTrials.gov
Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece
Primary completion· ClinicalTrials.gov
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis
Primary completion· ClinicalTrials.gov
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Primary completion· ClinicalTrials.gov
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Primary completion· ClinicalTrials.gov
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Primary completion· ClinicalTrials.gov
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK
Primary completion· ClinicalTrials.gov
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Primary completion· ClinicalTrials.gov
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Place
Primary completion· ClinicalTrials.gov
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
Past events
2026
Trial registered· ClinicalTrials.gov
Finerenone and Cardiac Remodeling in HFpEF
Trial started· ClinicalTrials.gov
Finerenone and Cardiac Remodeling in HFpEF
Primary completion· ClinicalTrials.gov
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone
FDA approval (supplemental)· FDA
Sponsor: BAYER HLTHCARE. Class: Efficacy.
Trial started· ClinicalTrials.gov
Finerenone for Premature Ovarian Insufficiency (POI)
Trial registered· ClinicalTrials.gov
Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide
Trial registered· ClinicalTrials.gov
Finerenone for Premature Ovarian Insufficiency (POI)
Trial registered· ClinicalTrials.gov
Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence
Trial started· ClinicalTrials.gov
Precision T1D Platform - New Therapies for Cardio-Renal Complications
Trial started· ClinicalTrials.gov
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Primary completion· ClinicalTrials.gov
Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide
Primary completion· ClinicalTrials.gov
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatme
Trial registered· ClinicalTrials.gov
Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot Trial
Trial registered· ClinicalTrials.gov
QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy
Primary completion· ClinicalTrials.gov
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone
Primary completion· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATI
Primary completion· ClinicalTrials.gov
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i
Trial started· ClinicalTrials.gov
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis
Trial registered· ClinicalTrials.gov
Finerenone for the Treatment of Type 2 Diabetes-Related Kidney Disease: Efficacy Observation and Related Factor Analysis
Results posted· ClinicalTrials.gov
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon
Trial registered· ClinicalTrials.gov
Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
Trial started· ClinicalTrials.gov
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
Trial started· ClinicalTrials.gov
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ
Primary completion· ClinicalTrials.gov
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
Trial registered· ClinicalTrials.gov
Finerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
Effect of Finerenone in IgA Nephropathy
Trial started· ClinicalTrials.gov
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults
Trial started· ClinicalTrials.gov
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK
Trial started· ClinicalTrials.gov
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic
Primary completion· ClinicalTrials.gov
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
Trial registered· ClinicalTrials.gov
Precision T1D Platform
Trial registered· ClinicalTrials.gov
Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With A
Trial registered· ClinicalTrials.gov
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
Primary completion· ClinicalTrials.gov
Finerenone Plus SGLT2 Inhibitors in Heart Failure
Trial started· ClinicalTrials.gov
Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure
Trial started· ClinicalTrials.gov
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Trial started· ClinicalTrials.gov
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK
Trial registered· ClinicalTrials.gov
An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CK
Trial registered· ClinicalTrials.gov
Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)
Trial registered· ClinicalTrials.gov
Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic
Trial registered· ClinicalTrials.gov
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Trial started· ClinicalTrials.gov
Simultaneous Starting of the 4 Guideline Directed CKD Therapies (RAPID-CKD)
Trial started· ClinicalTrials.gov
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Trial registered· ClinicalTrials.gov
Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure
Primary completion· ClinicalTrials.gov
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
Trial started· ClinicalTrials.gov
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Primary completion· ClinicalTrials.gov
An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How
Trial registered· ClinicalTrials.gov
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Trial registered· ClinicalTrials.gov
A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea
Trial registered· ClinicalTrials.gov
Finerenone Plus SGLT2 Inhibitors in Heart Failure
Trial started· ClinicalTrials.gov
Finerenone Plus SGLT2 Inhibitors in Heart Failure
Trial registered· ClinicalTrials.gov
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
Trial registered· ClinicalTrials.gov
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Pivotal publication· PubMed
FINE-ONE — A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type
Trial started· ClinicalTrials.gov
Finerenone for Cardiorenal Protection in Diabetic CKD: Impact on Renal Function Decline and Heart Failure
2025
Trial started· ClinicalTrials.gov
Finerenone and Cardiac Remodeling
Primary completion· ClinicalTrials.gov
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
Trial started· ClinicalTrials.gov
A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South Korea
Trial registered· ClinicalTrials.gov
Finerenone and Cardiac Remodeling
Trial started· ClinicalTrials.gov
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone
Primary completion· ClinicalTrials.gov
Finerenone and Renal Oxidative Stress
Trial started· ClinicalTrials.gov
Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease
Trial registered· ClinicalTrials.gov
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Trial started· ClinicalTrials.gov
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Trial started· ClinicalTrials.gov
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and T
Trial started· ClinicalTrials.gov
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Place
Trial registered· ClinicalTrials.gov
Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease
Primary completion· ClinicalTrials.gov
A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mel
Trial registered· ClinicalTrials.gov
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and T
Trial registered· ClinicalTrials.gov
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone
Primary completion· ClinicalTrials.gov
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patien
Trial started· ClinicalTrials.gov
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Trial registered· ClinicalTrials.gov
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults
Primary completion· ClinicalTrials.gov
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Trial registered· ClinicalTrials.gov
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Place
Trial started· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ
Trial registered· ClinicalTrials.gov
FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors
Trial registered· ClinicalTrials.gov
Role of Finerenone in African American Veterans With Diabetic Kidney Disease
Results posted· ClinicalTrials.gov
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection
Primary completion· ClinicalTrials.gov
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
Primary completion· ClinicalTrials.gov
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability
Trial registered· ClinicalTrials.gov
An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How
Trial registered· ClinicalTrials.gov
A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of
Trial started· ClinicalTrials.gov
An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How
FDA approval (supplemental)· FDA
Sponsor: BAYER HLTHCARE. Class: Efficacy.
Trial registered· ClinicalTrials.gov
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
Primary completion· ClinicalTrials.gov
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Abilit
Trial started· ClinicalTrials.gov
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Trial registered· ClinicalTrials.gov
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Trial started· ClinicalTrials.gov
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Primary completion· ClinicalTrials.gov
Finerenone for Patients With Primary Aldosteronism (FAIRY)
Primary completion· ClinicalTrials.gov
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
Trial started· ClinicalTrials.gov
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
Trial started· ClinicalTrials.gov
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Trial registered· ClinicalTrials.gov
Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
Trial registered· ClinicalTrials.gov
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Primary completion· ClinicalTrials.gov
Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
Primary completion· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Dia
Primary completion· ClinicalTrials.gov
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon
Primary completion· ClinicalTrials.gov
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
Trial started· ClinicalTrials.gov
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
Trial registered· ClinicalTrials.gov
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Trial registered· ClinicalTrials.gov
Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
Trial registered· ClinicalTrials.gov
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patien
Trial registered· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With Chronic Kidney Disease and Typ
Trial started· ClinicalTrials.gov
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patien
2024
Primary completion· ClinicalTrials.gov
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Trial started· ClinicalTrials.gov
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i
Trial registered· ClinicalTrials.gov
Use of Clinical-trials and Simulation Models to Estimate Cost-effectiveness of Non-steroidal Mineralocorticoid Antagonists, RASi and SGLT2i
Trial started· ClinicalTrials.gov
Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Trial started· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Dia
Trial started· ClinicalTrials.gov
Effect of Finerenone in IgA Nephropathy
Primary completion· ClinicalTrials.gov
An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well
Trial started· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Primary completion· ClinicalTrials.gov
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Trial registered· ClinicalTrials.gov
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Dia
Primary completion· ClinicalTrials.gov
An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How
Trial started· ClinicalTrials.gov
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Trial registered· ClinicalTrials.gov
Effect of Finerenone in IgA Nephropathy
Trial registered· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Trial started· ClinicalTrials.gov
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme
Trial started· ClinicalTrials.gov
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Trial started· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATI
Trial started· ClinicalTrials.gov
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Trial registered· ClinicalTrials.gov
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
Trial registered· ClinicalTrials.gov
Finerenone for Patients With Primary Aldosteronism (FAIRY)
Trial started· ClinicalTrials.gov
Finerenone for Patients With Primary Aldosteronism (FAIRY)
Trial started· ClinicalTrials.gov
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works
Primary completion· ClinicalTrials.gov
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection
Trial registered· ClinicalTrials.gov
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
Trial started· ClinicalTrials.gov
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Primary completion· ClinicalTrials.gov
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
Primary completion· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
Trial started· ClinicalTrials.gov
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
Trial registered· ClinicalTrials.gov
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works
Trial started· ClinicalTrials.gov
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability
Trial registered· ClinicalTrials.gov
Finerenone and Renal Oxidative Stress
Trial started· ClinicalTrials.gov
Finerenone and Renal Oxidative Stress
Trial started· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Pivotal publication· PubMed
FINEARTS-HF — Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Gr
Pivotal publication· PubMed
FINEARTS-HF — Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Gr
2023
Primary completion· ClinicalTrials.gov
An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-
Trial started· ClinicalTrials.gov
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Trial registered· ClinicalTrials.gov
Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Trial started· ClinicalTrials.gov
Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Trial registered· ClinicalTrials.gov
Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial
Trial registered· ClinicalTrials.gov
Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Trial registered· ClinicalTrials.gov
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Trial registered· ClinicalTrials.gov
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Trial registered· ClinicalTrials.gov
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme
Trial started· ClinicalTrials.gov
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
Trial registered· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients with Heart Failure (CONFIRMATI
Trial registered· ClinicalTrials.gov
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Trial started· ClinicalTrials.gov
A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mel
Trial started· ClinicalTrials.gov
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Primary completion· ClinicalTrials.gov
A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of
Trial registered· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
Trial started· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
Trial registered· ClinicalTrials.gov
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability
Trial registered· ClinicalTrials.gov
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Trial registered· ClinicalTrials.gov
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
Trial started· ClinicalTrials.gov
An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well
Trial started· ClinicalTrials.gov
Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
Trial started· ClinicalTrials.gov
A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of
Trial registered· ClinicalTrials.gov
Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
Results posted· ClinicalTrials.gov
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat
Trial started· ClinicalTrials.gov
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Abilit
Trial registered· ClinicalTrials.gov
An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Including How Safe it is and How Well
Trial registered· ClinicalTrials.gov
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Abilit
2022
Trial registered· ClinicalTrials.gov
An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-
Trial started· ClinicalTrials.gov
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
Trial started· ClinicalTrials.gov
An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-
Trial started· ClinicalTrials.gov
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece
Trial started· ClinicalTrials.gov
An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How
Trial registered· ClinicalTrials.gov
A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mel
Trial registered· ClinicalTrials.gov
An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How
FDA approval (supplemental)· FDA
Sponsor: BAYER HLTHCARE. Class: Efficacy.
Trial registered· ClinicalTrials.gov
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Rece
Trial started· ClinicalTrials.gov
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon
Trial started· ClinicalTrials.gov
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Trial registered· ClinicalTrials.gov
A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting
Results posted· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
Trial started· ClinicalTrials.gov
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,
Trial registered· ClinicalTrials.gov
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alon
Trial registered· ClinicalTrials.gov
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body,
2021
Primary completion· ClinicalTrials.gov
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat
Trial started· ClinicalTrials.gov
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
Trial registered· ClinicalTrials.gov
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
Trial registered· ClinicalTrials.gov
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat
Trial started· ClinicalTrials.gov
An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicat
Results posted· ClinicalTrials.gov
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
FDA approval· FDA
Sponsor: BAYER HLTHCARE. Class: Type 1 - New Molecular Entity.
Primary completion· ClinicalTrials.gov
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine
Primary completion· ClinicalTrials.gov
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Fine
Results posted· ClinicalTrials.gov
Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricu
Trial registered· ClinicalTrials.gov
A Study to Learn How BAY94-8862 Moves Into, Through and Out of the Body, How Safe it is and How it Affects the Body in Adult Participants Wi
Trial registered· ClinicalTrials.gov
A Study to Learn How Finerenone (BAY94-8862) Moves Into, Through and Out of the Body, How it Affects the Body, and How Safe it is in Adult P
Results posted· ClinicalTrials.gov
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic N
Sources
FDA approvals, label revisions, and recalls come from the public openFDA APIs (Drugs@FDA, Drug Label, Drug Enforcement). Drug-safety communications come from the FDA RSS feed. Trial milestones come from ClinicalTrials.gov via the AACT pg dump. Pivotal-publication events come from PubMed, filtered to high-impact journals linked to a Phase 3 trial in our inventory.